5% glucose
baxter healthcare ltd - glucose monohydrate 50 g/l - solution for infusion - 5 % - active: glucose monohydrate 50 g/l excipient: water for injection - glucose (5%) intravenous infusions are mainly indicated: whenever non-electrolyte fluid replacement is required. as a vehicle for drug delivery, provided that the added components are compatible with glucose.
potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 5% infusion 500ml bags
potassium 10mmol/500ml) / glucose 5% infusion 500ml bags (baxter healthcare ltd - glucose anhydrous; potassium chloride - infusion - 50mg/1ml ; 1.5mg/1ml
potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre viaflo bags
potassium 40mmol/1litre) / glucose 4% / sodium chloride 0.18% infusion 1litre viaflo bags (baxter healthcare ltd - glucose anhydrous; potassium chloride; sodium chloride - infusion - 40mg/1ml ; 3mg/1ml ; 1.8mg/1ml
potassium chloride 0.3% (potassium 40mmol/1litre) / glucose 5% infusion 1litre viaflo bags
potassium 40mmol/1litre) / glucose 5% infusion 1litre viaflo bags (baxter healthcare ltd - glucose anhydrous; potassium chloride - infusion - 50mg/1ml ; 3mg/1ml
viaflo 5% glucose 50g/1000ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 25g/500ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 12.5g/250ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 100ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
viaflo 5% glucose 50ml injection bag
baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.
glucose 10% w/v
fresenius kabi new zealand limited - glucose monohydrate 110 g/l equivalent to glucose 100 g/l; - solution for infusion - 100 g/l - active: glucose monohydrate 110 g/l equivalent to glucose 100 g/l excipient: hydrochloric acid sodium hydroxide water for injection - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used. b) gastrointestinal absorption of protein is impaired. c) metabolic requirements for protein are substantially increased, as with extensive burns.